Cellectar Biosciences (CLRB) Misses Q1 EPS by 21c

Cellectar Biosciences (NASDAQ: CLRB) reported Q1 EPS of ($0.74), $0.21 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c